Affinage

POLD4

DNA polymerase delta subunit 4 · UniProt Q9HCU8

Length
107 aa
Mass
12.4 kDa
Annotated
2026-06-10
12 papers in source corpus 10 papers cited in narrative 12 extracted findings
Cross-family judge vs UniProt: tie faithfulness: 6/6 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

POLD4 (p12) is the smallest subunit of the DNA polymerase δ holoenzyme and acts at the interface of DNA replication and genome stability maintenance (PMID:19931513, PMID:20861182). Biochemically it is a stimulatory subunit: pol δ lacking POLD4 shows reduced DNA synthesis activity in vitro regardless of the presence of the processivity clamp PCNA (PMID:19931513, PMID:20861182), and it engages PCNA directly through a non-canonical N-terminal PIP motif that inserts a conserved glutamine into the PCNA Q-pocket and uses conserved leucine/phenylalanine residues in a compact two-fork plug rather than the canonical 3₁₀-helix (PMID:35942639). Loss of POLD4 provokes replication stress, checkpoint activation, cell-cycle delay, and elevated chromosomal gap/break frequency, with the G1–S block executed through suppression of Akt–Skp2 signaling and consequent p27 accumulation (PMID:19931513, PMID:20861182, PMID:24618301). At stressed forks POLD4 enforces a protective replication-repair choice: it suppresses replication-associated homologous recombination (IgV gene conversion) without affecting general HR (PMID:33588156), and it promotes PARP1–Polε-exonuclease–mediated fork reversal when the lagging-strand template carries single-strand breaks, thereby preventing conversion of those lesions into double-strand breaks (PMID:38678695). POLD4 is post-translationally regulated by proteasomal turnover and is stabilized by the deubiquitinase UCHL3, which directly binds and deubiquitinates it; the UCHL3–POLD4 axis supports HR and NHEJ, tumor cell self-renewal, and radioresistance (PMID:26998273, PMID:38829550). POLD4 is dispensable for normal mammalian development, as Pold4 knockout mice are viable and fertile with normal replication and repair in primary cells, indicating its functions become critical chiefly under replication stress and in cancer contexts (PMID:36356905).

Mechanistic history

Synthesis pass · year-by-year structured walk · 10 steps
  1. 2009 Medium

    Established that POLD4 is not a passive structural subunit but is biochemically required for full pol δ catalytic output, and that its loss has cellular consequences for proliferation and genome integrity.

    Evidence In vitro pol δ synthesis assays ± POLD4 ± PCNA, plus shRNA knockdown with colony-formation and morphology readouts in lung cancer cells

    PMID:19931513

    Open questions at the time
    • Mechanism by which POLD4 stimulates synthesis not resolved
    • Single lab
    • Cellular phenotype not yet tied to a defined replication-stress pathway
  2. 2010 High

    Confirmed by reciprocal knockdown and rescue that POLD4 loss specifically drives checkpoint activation, cell-cycle delay, and chromosomal breakage, linking the biochemical defect to a double-strand-break-suppression role.

    Evidence siRNA knockdown with siRNA-resistant rescue, γ-H2AX immunofluorescence, cell-cycle analysis and chromosomal break scoring; in vitro synthesis assay

    PMID:19931513 PMID:20861182

    Open questions at the time
    • Molecular mechanism linking POLD4 loss to breaks not defined
    • Single lab
    • No structural basis for stimulation
  3. 2014 Medium

    Identified the signaling route for the G1–S block, showing POLD4 loss suppresses Akt–Skp2 signaling and elevates p27.

    Evidence siRNA knockdown with rescue and western blots for p-Akt(Ser473), Skp2, p27 plus cell-cycle analysis in Calu6 cells

    PMID:24618301

    Open questions at the time
    • Whether Akt-Skp2-p27 changes are direct or secondary to replication stress unresolved
    • Single cell line/lab
  4. 2016 Medium

    Showed POLD4 abundance is controlled by proteasomal degradation, providing a regulatory node responsive to genotoxic carcinogen exposure.

    Evidence Western blot of POLD4 after 4NQO treatment ± MG132 proteasome inhibitor in A549 cells

    PMID:26998273

    Open questions at the time
    • E3 ligase and ubiquitination sites not identified
    • Single method, single lab
  5. 2021 High

    Distinguished POLD4's role at replication forks from general recombination, defining it as a suppressor of replication-associated HR gene conversion specifically.

    Evidence POLD4 knockout DT40 cells with IgV gene-conversion, sister-chromatid-exchange, and I-SceI gene-targeting assays

    PMID:33588156

    Open questions at the time
    • Molecular step at which POLD4 channels lesions away from gene conversion unclear
    • Single lab
    • Chicken model system
  6. 2022 High

    Provided the structural basis for POLD4-PCNA engagement, revealing a non-canonical PIP-box binding mode distinct from typical PIP motifs.

    Evidence X-ray crystal structure (2.45 Å) of C. thermophilum PolD4 PIP motif bound to PCNA, with ITC affinity measurement validated against human p12

    PMID:35942639

    Open questions at the time
    • Functional consequence of this non-canonical binding for pol δ activity in cells not tested
    • Orthologous protein rather than human
  7. 2022 Medium

    Demonstrated POLD4 is dispensable for normal development and basal replication/repair, bounding its essential functions to stress and cancer contexts.

    Evidence Pold4 knockout mouse with histopathology, plus fibroblast growth, cell-cycle, replication and damage/repair assays

    PMID:36356905

    Open questions at the time
    • Does not exclude subtle phenotypes under replication stress in vivo
    • Single lab
  8. 2024 High

    Identified UCHL3 as a direct deubiquitinase that stabilizes POLD4, linking POLD4 abundance to DNA-repair capacity, tumor self-renewal, and radioresistance.

    Evidence Reciprocal Co-IP, GST pull-down, deubiquitination assay, HR/NHEJ reporters, and intracranial xenograft in glioma stem cells

    PMID:38829550

    Open questions at the time
    • Ubiquitin linkage type and target lysines on POLD4 not mapped
    • Relationship to proteasomal turnover seen with carcinogen exposure not integrated
    • Single lab
  9. 2024 High

    Placed POLD4 mechanistically in a PARP1–Polε-exonuclease fork-reversal pathway that protects lagging-strand replication from single-strand-break-derived double-strand breaks.

    Evidence POLD4 knockout DT40 cells with camptothecin sensitivity and multi-gene epistasis using PARP1-/- and POLE1exo-/- double knockouts

    PMID:38678695

    Open questions at the time
    • Direct biochemical role of POLD4 in fork reversal not reconstituted
    • Single lab
    • Chicken model system
  10. 2024 Medium

    Implicated POLD4 in break-induced replication-driven genomic amplification, extending its role beyond fork protection to conservative DNA synthesis at breaks.

    Evidence POLD4 depletion/deletion with DIGA quantification and genetic interaction with POLD3 and RAD52 (preprint)

    PMID:bio_10.1101_2024.08.27.609980

    Open questions at the time
    • Preprint, not peer-reviewed
    • Whether POLD4 acts through canonical pol δ or a distinct BIR complex unresolved

Open questions

Synthesis pass · forward-looking unresolved questions
  • How POLD4's stimulatory and PCNA-binding biochemistry mechanistically translates into its fork-protection, recombination-suppression, and BIR roles, and what governs the choice between these outcomes, remains unresolved.
  • No reconstitution connecting PCNA binding to fork reversal
  • Ubiquitination/deubiquitination regulatory logic incomplete
  • Human in vivo relevance under stress untested

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0003677 DNA binding 2 GO:0098772 molecular function regulator activity 2 GO:0140097 catalytic activity, acting on DNA 2
Localization
GO:0005634 nucleus 2
Pathway
R-HSA-1640170 Cell Cycle 2 R-HSA-69306 DNA Replication 2 R-HSA-73894 DNA Repair 2
Partners
Complex memberships
DNA polymerase delta complex

Evidence

Reading pass · 12 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2009 POLD4 is required for full in vitro DNA synthesis activity of pol δ; pol δ lacking POLD4 shows reduced activity regardless of whether the processivity factor PCNA is present. In vitro DNA polymerase activity assay with and without POLD4, with and without PCNA Biochemical and biophysical research communications Medium 19931513
2009 shRNA-mediated reduction of POLD4 in lung cancer cells results in increased karyomere-like cells (indicative of replication stress/DNA damage) and reduced colony formation, establishing a role for POLD4 in cell proliferation and genomic stability maintenance. shRNA knockdown, colony formation assay, cell morphology analysis Biochemical and biophysical research communications Medium 19931513
2010 siRNA-mediated reduction of POLD4 causes cell cycle delay, checkpoint activation, and elevated chromosomal gap/break frequency; rescue by siRNA-resistant POLD4 confirmed these effects are specifically due to POLD4 loss. POLD4 overexpression reduced γ-H2AX induction, further linking POLD4 to DNA double-strand break suppression. siRNA knockdown, rescue with siRNA-resistant POLD4 construct, cell cycle analysis, γ-H2AX immunofluorescence, chromosomal gap/break scoring Cancer research High 20861182
2010 In vitro, pol δ exhibits impaired DNA synthesis activity in the absence of POLD4, confirming POLD4 as a stimulatory subunit of the pol δ complex. In vitro DNA synthesis assay with pol δ complexes with/without POLD4 Cancer research Medium 19931513 20861182
2014 POLD4 knockdown in Calu6 lung cancer cells suppresses the Akt-Skp2-p27 signaling pathway: reduced POLD4 leads to decreased phospho-Akt (Ser473) and Skp2 and increased p27, causing G1-S cell cycle blockage. Rescue with siRNA-resistant POLD4 restored these protein expression levels. siRNA knockdown, rescue with siRNA-resistant POLD4, western blot for p-Akt, Skp2, p27, cell cycle analysis Bioorganic & medicinal chemistry letters Medium 24618301
2016 POLD4 protein levels in A549 cells decrease following treatment with the carcinogen 4-nitroquinoline-1-oxide (4NQO), and this decrease is reversed by MG132, a proteasome inhibitor, indicating that 4NQO-induced POLD4 downregulation occurs via proteasomal degradation. Western blot with/without MG132 proteasome inhibitor treatment Biomedical reports Medium 26998273
2021 In chicken DT40 cells, POLD4 deletion increases the rate and tract length of IgV gene conversion (HR-mediated), altering pseudo-V segment usage, without affecting general HR (sister chromatid exchange or gene targeting at I-SceI-induced DSBs). This places POLD4 as a suppressor of replication-associated HR gene conversion specifically. POLD4 knockout cells, IgV gene conversion assay, sister-chromatid exchange assay, I-SceI-induced gene targeting assay DNA repair High 33588156
2022 X-ray crystal structure of the N-terminal PIP motif of Chaetomium thermophilum PolD4 (ortholog of human POLD4/p12) bound to PCNA at 2.45 Å resolution reveals non-canonical binding: the PIP motif lacks the typical 310 helix and instead uses a conserved glutamine inserted into the Q-pocket and conserved leucine/phenylalanine in a compact 2-fork plug to engage the PCNA hydrophobic pocket. ITC confirms similar affinity to human p12. X-ray crystallography (2.45 Å), isothermal calorimetry (ITC) The FEBS journal High 35942639
2022 Pold4 knockout mice are viable and fertile with no detectable pathological changes; knockout mouse fibroblasts show normal cell growth, cell cycle, DNA replication, and DNA damage/repair capacity, indicating that the trimeric pol δ3 (lacking POLD4) is sufficient for these processes in normal mammalian cells. Pold4 knockout mouse model, histopathology, cell growth assay, cell cycle analysis, DNA replication and repair assays in tail-tip fibroblasts Gene Medium 36356905
2024 UCHL3, a deubiquitinase in the UCH protease family, directly interacts with POLD4, depolyubiquitinates it, and thereby stabilizes POLD4 protein in glioma stem cells. Loss of the UCHL3-POLD4 axis impairs homologous recombination and non-homologous end joining, reducing GSC self-renewal, tumorigenic capacity, and ionizing radiation resistance. Co-immunoprecipitation, GST pull-down, ubiquitination assay, intracranial xenograft mouse model, HR/NHEJ reporter assays Cellular and molecular life sciences : CMLS High 38829550
2024 Pold4 promotes fork reversal during lagging-strand replication encountering single-strand breaks: POLD4-/- cells show selective sensitivity to camptothecin (a topoisomerase I inhibitor that generates SSBs during replication). Epistasis analysis using PARP1-/-, POLD4-/-, POLE1exo-/- and double-KO cells placed Pold4 in the PARP1-Polε exonuclease-mediated fork reversal pathway, suppressing DSBs arising from lagging-strand stalling on broken templates. POLD4 knockout DT40 cells, camptothecin and other DNA-damaging agent sensitivity assays, genetic epistasis with PARP1-/- and POLE1exo-/- double knockouts DNA repair High 38678695
2024 Depletion or deletion of POLD4 significantly inhibits DSB-induced large-scale genomic amplification (DIGA) in human cancer cells, placing POLD4 as a component of the break-induced replication (BIR) machinery mediating conservative DNA synthesis-driven genomic amplification. POLD4 depletion/deletion, DIGA quantification following IR and DSB-inducing agents, genetic interaction with POLD3 and RAD52 bioRxivpreprint Medium bio_10.1101_2024.08.27.609980

Source papers

Stage 0 corpus · 12 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2010 Regulation of DNA polymerase POLD4 influences genomic instability in lung cancer. Cancer research 45 20861182
2009 Roles of POLD4, smallest subunit of DNA polymerase delta, in nuclear structures and genomic stability of human cells. Biochemical and biophysical research communications 37 19931513
2020 Circular RNA circ_0026359 Enhances Cisplatin Resistance in Gastric Cancer via Targeting miR-1200/POLD4 Pathway. BioMed research international 36 32855967
2024 UCHL3 induces radiation resistance and acquisition of mesenchymal phenotypes by deubiquitinating POLD4 in glioma stem cells. Cellular and molecular life sciences : CMLS 10 38829550
2021 Pold4, the fourth subunit of replicative polymerase δ, suppresses gene conversion in the immunoglobulin-variable gene in avian DT40 cells. DNA repair 8 33588156
2016 4-Nitroquinoline-1-oxide effects human lung adenocarcinoma A549 cells by regulating the expression of POLD4. Biomedical reports 8 26998273
2014 Downregulation of POLD4 in Calu6 cells results in G1-S blockage through suppression of the Akt-Skp2-p27 pathway. Bioorganic & medicinal chemistry letters 7 24618301
2023 POLD4 Promotes Glioma Cell Proliferation and Suppressive Immune Microenvironment: A Pan-Cancer Analysis Integrated with Experimental Validation. International journal of molecular sciences 6 37762224
2024 Pold4 subunit of replicative polymerase δ promotes fork slowing at broken templates. DNA repair 5 38678695
2022 Pold4 is dispensable for mouse development, DNA replication and DNA repair. Gene 4 36356905
2022 Non-canonical binding of the Chaetomium thermophilum PolD4 N-terminal PIP motif to PCNA involves Q-pocket and compact 2-fork plug interactions but no 310 helix. The FEBS journal 2 35942639
2026 CRISPR-Cas9-Loaded Theranostic Liposomes for Enhancing Radiosensitization of Prostate Cancer through POLD4 Gene Editing under Real-Time MRI Monitoring. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 0 41498761

Missed literature

Know a paper Affinage missed for POLD4? Flag it for the maintainers and the community.

No submissions yet.